aibio.space Earnings Desk
Quarterly and annual results: revenue, net loss, cash, runway and guidance, from 10-Q, 10-K, 20-F and 6-K filings and company releases.
Sources: SEC filings and company press releases, with wires, trade press and court dockets used as leads and confirmed against a filing. The desk follows our editorial standards. 93 stories so far.
Latest stories
- PTC reports third-quarter 2026 revenue of $358 million and raises product guidance
- 60 Degrees reports PCR-negative results in five babesiosis patients
- Cosmos Health expects fourth-quarter U.S. revenue of about $15 million
- Interpace Biosciences expects third quarter revenue of $10.1 million to $10.4 million
- Scienture expects preliminary third-quarter revenue of about $1.22 million
- Cosmos Health reports preliminary nine-month revenue of $54.3 million
- Q32 Bio reports Week 36 SIGNAL-AA Part B results for bempikibart
- Jaguar Health reports second quarter 2026 net loss of $12.7 million
- Cosmos Health reports second-quarter 2026 revenue of $18.99 million
- Intelligent Bio Solutions reports fiscal 2026 revenue of $4,215,175
- Quoin reports second quarter 2026 results and QRX003 progress
- Traws Pharma reports Q2 2026 results and updated MHRA timeline
- Retractable Technologies reports second-quarter net sales of $7.2 million
- Lifeward reports second quarter 2026 revenue up 16% to $6.6 million
- LeonaBio reports second quarter 2026 results and ELAINE-3 update
- PAVmed reports second quarter 2026 results and Lucid coverage policy
- Vycor Medical reports second quarter 2026 results
- Enveric reports second quarter 2026 net loss of $3.0 million
- Scienture reports second quarter 2026 revenue of $343,639
- Lifeloc reports second-quarter 2026 revenue up 10%
- Dogwood reports second quarter 2026 results and Halneuron update
- Nuwellis reports 14% second-quarter revenue growth and 76% gross margin
- MiNK reports second quarter 2026 results and early trial observations
- Tenon Medical reports second quarter 2026 revenue of $1.3 million
- Biofrontera reports second-quarter 2026 net product revenue of $12.0 million
- Co-Diagnostics reports second quarter 2026 results and flu and RSV test submission
- Aethlon reports first-quarter fiscal 2027 results and third-cohort dosing
- Aprea reports second-quarter 2026 results and $41.2 million in cash
- Mannatech reports second quarter 2026 net income of $1.0 million
- AEON reports second-quarter 2026 results and a $15.3 million financing
- Bolt Biotherapeutics reports second-quarter results and cash into 2027
- Dermata reports second-quarter 2026 results and $4.4 million in cash
- Intensity Therapeutics reports Q2 2026 results and trial updates
- Palisade Bio reports second quarter 2026 results and Phase 2 plans for PALI-2108
- Bionano reports second quarter 2026 revenue of $8.2 million
- Interpace Biosciences reports second quarter revenue of $9.1 million
- Minerva Neurosciences reports second quarter 2026 results and C19 trial progress
- Kiora reports second quarter 2026 results and cash runway into late 2028
- MetaVia reports second quarter 2026 net loss of $5.3 million
- IN8bio reports second quarter 2026 results and glioblastoma survival data
aibio